Cat. No.: DIA-0230648
Product Information | |
---|---|
CAS No. | 664969-54-4 |
Formula | C20H24N4O2S2 |
Molecular Weight | 416.56 |
SMILES | N[S](=O)(=O)C1=CC=C(NC(=S)N2CCN(CC2)C\C=C\C3=CC=CC=C3)C=C1 |
Product Description | LF3 is a specific inhibitor of canonical Wnt signaling by disrupting the interaction between β-catenin and TCF4 with an IC50 less than 2 μM. |
Format & Storage | |
---|---|
Purity | > 97% |
Shipping | Shipped on dry ice. |
Storage | Powder: -20 °C, 3 years; 4 °C, 2 years In solvent: -80 °C, 6 months; -20 °C, 1 month |
Solubility Overview | Soluble in DMSO |
Ace Therapeutics has a team of experts in the field of endocrine and metabolic research, aiming to provide innovative preclinical contract research solutions to cope with diabetes and its complications. We provide customized solutions and technical support, enabling the transformation of promising concepts into innovative treatments, thus accelerating the drug development process of diabetes.